DK422786A - Rekombinant-dna-sekvens til styring af den intracellulaere produktionaf metalloproteinase-inhibitorer og fremgangsmaade til fremstillingaf en saadan sekvens - Google Patents

Rekombinant-dna-sekvens til styring af den intracellulaere produktionaf metalloproteinase-inhibitorer og fremgangsmaade til fremstillingaf en saadan sekvens Download PDF

Info

Publication number
DK422786A
DK422786A DK422786A DK422786A DK422786A DK 422786 A DK422786 A DK 422786A DK 422786 A DK422786 A DK 422786A DK 422786 A DK422786 A DK 422786A DK 422786 A DK422786 A DK 422786A
Authority
DK
Denmark
Prior art keywords
sequence
dna sequence
preparing
procedure
control
Prior art date
Application number
DK422786A
Other languages
English (en)
Other versions
DK422786D0 (da
DK175964B1 (da
Inventor
David F Carmichael
David C Anderson
George P Stricklin
Howard G Welgus
Original Assignee
Synergen Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Biolog Inc filed Critical Synergen Biolog Inc
Publication of DK422786D0 publication Critical patent/DK422786D0/da
Publication of DK422786A publication Critical patent/DK422786A/da
Application granted granted Critical
Publication of DK175964B1 publication Critical patent/DK175964B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198604227A 1985-02-05 1986-09-04 Rekombinant metalloproteinaseinhibitorsekvensvektorsystem, anvendelse af denne samt rekombinant DNA-fremgangsmåde til fremstilling af denne DK175964B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US69918185A 1985-02-05 1985-02-05
US69918185 1985-02-05
US78431985A 1985-10-04 1985-10-04
US78431985 1985-10-04
US8600302 1986-02-05
PCT/US1986/000302 WO1986004608A1 (en) 1985-02-05 1986-02-05 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same

Publications (3)

Publication Number Publication Date
DK422786D0 DK422786D0 (da) 1986-09-04
DK422786A true DK422786A (da) 1986-12-05
DK175964B1 DK175964B1 (da) 2005-09-26

Family

ID=27106361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198604227A DK175964B1 (da) 1985-02-05 1986-09-04 Rekombinant metalloproteinaseinhibitorsekvensvektorsystem, anvendelse af denne samt rekombinant DNA-fremgangsmåde til fremstilling af denne

Country Status (9)

Country Link
US (3) US6090585A (da)
EP (1) EP0211077B1 (da)
JP (1) JPH088870B2 (da)
KR (1) KR940010862B1 (da)
AT (1) ATE89005T1 (da)
AU (2) AU5549386A (da)
DE (1) DE3688383T2 (da)
DK (1) DK175964B1 (da)
WO (1) WO1986004608A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62500424A (ja) * 1984-10-01 1987-02-26 サンド・リミテッド 赤血球の増強活性を有する蛋白質のための遺伝子を含有するベクタ−および前記蛋白質を生産するための組み換えｄｎａ法
EP0188312A3 (en) * 1985-01-07 1988-01-13 Celltech Limited Process for the production of a protein
JPH01213232A (ja) * 1988-02-22 1989-08-28 Fuji Yakuhin Kogyo Kk 新規な皮膚潰瘍治療剤
JP2877509B2 (ja) * 1989-05-19 1999-03-31 アムジエン・インコーポレーテツド メタロプロテイナーゼ阻害剤
US5714465A (en) 1989-05-19 1998-02-03 Amgen Inc. Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
BR9712900A (pt) 1996-11-06 2000-11-28 Univ California Enzima liberadora de receptor de fator de necrose de tumor isolado, composições que compreendem a enzima e métodos de utilização da mesma
ATE414100T1 (de) * 2001-07-02 2008-11-15 Merrion Res Iii Ltd Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
WO2008027861A1 (en) * 2006-08-30 2008-03-06 Ge Healthcare Bio-Sciences Corp. System and method for characterizing membranes and membrane filtration devices
US8189753B1 (en) 2007-04-12 2012-05-29 Russound/Fmp Incorporated Distributed intercom system with audio bus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4382081A (en) * 1981-06-12 1983-05-03 E. R. Squibb & Sons, Inc. Inhibitors of mammalian collagenase
US4361574A (en) * 1981-10-02 1982-11-30 American Home Products Corporation Inhibitors of mammalian collagenase
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
GR79124B (da) * 1982-12-22 1984-10-02 Genentech Inc
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
WO1984003711A1 (en) * 1983-03-25 1984-09-27 Celltech Ltd A process for the production of a protein
US4609667A (en) * 1983-12-19 1986-09-02 American Home Products Corporation Inhibitor of mammalian collagenase and elastase
US4602006A (en) * 1984-05-09 1986-07-22 Syntex (U.S.A.) Inc. Ynenolactone protease inhibitors
JPS62500424A (ja) * 1984-10-01 1987-02-26 サンド・リミテッド 赤血球の増強活性を有する蛋白質のための遺伝子を含有するベクタ−および前記蛋白質を生産するための組み換えｄｎａ法
GB8500341D0 (en) * 1985-01-07 1985-02-13 Celltech Ltd Production of protein
EP0188312A3 (en) * 1985-01-07 1988-01-13 Celltech Limited Process for the production of a protein
DE3666826D1 (en) * 1985-01-18 1989-12-14 Searle & Co Human natural inhibitor of collagenases
US4897444A (en) * 1985-05-31 1990-01-30 The Research Foundation Of The State University Of New York Immobilized fluorogenic substrates for enzymes; and processes for their preparation

Also Published As

Publication number Publication date
DE3688383T2 (de) 1993-08-26
EP0211077B1 (en) 1993-05-05
KR870700096A (ko) 1987-02-28
KR940010862B1 (ko) 1994-11-18
AU636370B2 (en) 1993-04-29
ATE89005T1 (de) 1993-05-15
US20030003556A1 (en) 2003-01-02
WO1986004608A1 (en) 1986-08-14
JPH088870B2 (ja) 1996-01-31
US6090585A (en) 2000-07-18
JPS62502101A (ja) 1987-08-20
AU5971090A (en) 1990-11-01
DK422786D0 (da) 1986-09-04
US6342374B1 (en) 2002-01-29
EP0211077A1 (en) 1987-02-25
DE3688383D1 (de) 1993-06-09
US6800732B2 (en) 2004-10-05
AU5549386A (en) 1986-08-26
DK175964B1 (da) 2005-09-26
EP0211077A4 (en) 1987-11-23

Similar Documents

Publication Publication Date Title
DK188582A (da) Bacillus-kloningsvektorer rekombinations-dna-molekyler bacillus-vaerter transformeret dermed samt fremgangsmaader til ekspressionaf fremmede dna-sekvenser og fremstilling af polypeptideer som er kodede dermed
BR0214350A (pt) Sequências de ácido nucleico e aminoácido de adenovìrus de sìmio, vetores contendo as mesmas e métodos de uso
DK240090D0 (da) Dna og anvendelse deraf
DE69232537D1 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
ATE76430T1 (de) Dna-transformationsvektoren.
DK547185D0 (da) Vektorer til ekspression af hirudin, transformerede celler og fremgangsmaade til fremstilling af hirudin
DK0555370T3 (da) Metoder og anvendelser for effektive, genetiske suppressorelementer
DK0792363T3 (da) Nye pesticide proteiner og stammer
EP0205475A4 (en) RECOMBINANT METHOD FOR THE PRODUCTION OF SERINE PROTEASE INHIBITORS, AND DNA SEQUENCES THEREOF.
DK659287D0 (da) Ekspression af det klonede lysostaphin-gen
DK422786A (da) Rekombinant-dna-sekvens til styring af den intracellulaere produktionaf metalloproteinase-inhibitorer og fremgangsmaade til fremstillingaf en saadan sekvens
DK0832258T3 (da) Opstrøms aktivatorsekvenser og rekombinante promotorsekvenser, der er funktionelle i Yarrowia og vektorer indeholdende disse
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
DK0476233T3 (da) Humant MK gen og proteinsekvens
DK0821063T3 (da) Forbedret riboflavinproduktion
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
ATE80179T1 (de) Modifiziertes pertussistoxin.
DE69332514D1 (de) Transformation von Phaffia Rhodozyma
NZ219789A (en) Method for enhancing protein production in bacteria by employing a specific ribosome binding site
DK0941341T3 (da) Nukleotidsekvens, der koder for en flavinmonooxygenase, det tilsvarende protein og deres anvendelser inden for diagnostik og terapi
AU2253288A (en) Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
SE8303714L (sv) Bovin-kalvkymosin
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
DE3577726D1 (de) Psm112-plasmidvektor zur expression in bacillus subtilis.

Legal Events

Date Code Title Description
PUP Patent expired